High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu
- 1 March 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9056) , 921-922
- https://doi.org/10.1016/s0140-6736(05)62696-7
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Atovaquone and proguanil for Plasmodium falciparum malariaThe Lancet, 1996
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- The activation of the biguanide antimalarial proguanil co‐segregates with the mephenytoin oxidation polymorphism‐a panel study.British Journal of Clinical Pharmacology, 1991